TIPRL Depletion Enhances the Sensitivity of Lung CSCs to Afatinib and Impairs Tumor Growth and Metastasis through CaMKK2 Signaling Inhibition In Vitro and In Vivo. The gene discussed is CAMKK2; the disease is neoplasm.